Peter Smith

Director/Miembro de la Junta en RYVU THERAPEUTICS S.A. .

Health Technology

Consumer Services

Finance

Perfil

Dr. Peter Smith is an Advisor at Atlas Venture Advisors, Inc., a Chief Scientific Officer at Amplify Medicines, Inc. and a President & Chief Executive Officer at Remix Therapeutics, Inc. He is on the Board of Directors at Ryvu Therapeutics SA. Dr. Smith was previously employed as a Chief Scientific Officer by H3 Biomedicine, Inc. He received his undergraduate degree from the University of Sheffield Medical School and a doctorate degree from Newcastle University.

Cargos activos de Peter Smith

Empresas	Cargo	Inicio
RYVU THERAPEUTICS S.A.	Director/Miembro de la Junta	14/06/2023
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Director Ejecutivo	17/08/2021
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.	Consultor / Asesor	01/01/2018
Amplify Medicines, Inc. Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The company is based in Boston, MA. The company was founded by Peter Smith.	Fundador	-

Todos los cargos activos de Peter Smith

Antiguos cargos conocidos de Peter Smith.

Empresas	Cargo	Fin
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Corporate Officer/Principal	31/12/2018

Ver el detalle de la experiencia de Peter Smith.

Formación de Peter Smith.

Newcastle University	Doctorate Degree
University of Sheffield Medical School	Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Peter Smith.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
RYVU THERAPEUTICS S.A.	Health Technology

Empresas privadas	4
Atlas Venture Advisors, Inc. Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors Inc (Atlas Venture Advisors) is a venture capital firm founded in 1980 by Christopher Julian Spray. The firm is headquartered in Cambridge, Massachusetts.	Finance
H3 Biomedicine, Inc. H3 Biomedicine, Inc. Pharmaceuticals: MajorHealth Technology Part of Eisai Co., Ltd., H3 Biomedicine, Inc. is a precision oncology research and development subsidiary based in Cambridge, MA. The company is uniquely positioned to integrate real-world clinical evidence with the latest advances in cancer genomics. H3 is developing a pipeline of highly targeted, breakthrough medicines that have the potential to impact the future of cancer care and treatment. The CEO of the company is Takashi Owa.	Health Technology
Remix Therapeutics, Inc. Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.	Health Technology
Amplify Medicines, Inc. Amplify Medicines, Inc. Pharmaceuticals: GenericHealth Technology Part of Ikena Oncology, Inc., Amplify Medicines, Inc. develops pharmaceutical drugs. The company is based in Boston, MA. The company was founded by Peter Smith.	Health Technology

Ver las conexiones de la empresa